The American Cancer Society has just updated its guidelines for colorectal cancer screening, lowering the age people at average risk should begin screening from 50 to 45.
Colon cancer is one of the leading causes of cancer death in the US. A primary goal goal of screening is to find the disease as early as possible when it’s small and easier to treat, since early stage colorectal cancer has a 90% survival rate.
“Equally important, screening can identify pre-cancerous polyps that may take up to a decade to become cancerous,” explains CMI Medical Director, Dr. Mark Baganz. “When these benign polyps are found and removed early enough, we can actually prevent cancer from ever occurring.”
A study released in 2017 that found a rise in colon and rectal cancers among younger adults, played a key role in the decision to update these recommendations. According to Stacy Simon, Senior Editor of the Journal of the National Cancer Institute, “The numbers showed that new cases of colorectal cancer are occurring at an increasing rate among younger adults. Beginning screening at an age of 45 for adults of average risk will result in more lives saved.”
“Of the many types of colon cancer screening tests currently available, there are three with sufficient accuracy to recommend routinely: fiberoptic (traditional) colonoscopy, CT (virtual) colonography, and stool DNA testing (i.e. Cologuard). Whichever test you and your doctor choose, the critical message here is to get screened.”
Does WHERE you get your mammogram really matter?
Yes, it does.
Low quality mammograms can increase false positives and screening discomfort, and possibly even delay cancer diagnoses — this according to a study recently published in the Canadian Association of Radiologists Journal. And the quality of mammography screening continues to vary widely and substantially from practice to practice.
The study, conducted by Marie-Hélène Guertin, PhD, and colleagues, notes that compromising the quality of mammograms can lead to lower screening sensitivity as well as delayed or possibly missed cancer diagnosis. In fact, lower overall mammography quality was associated with a 40% increase in the rate of false positives, leading to more anxiety for patients and uneccessary biopsies.
Conversely, high-quality mammography — like the fully digital screening at Chesapeake Medical Imaging — ensures clear visualization of all breast tissue, decreasing false positives and potentially resulting in earlier breast cancer diagnoses.
“It is important for women to not only follow the recommended schedule for annual breast cancer screening, but also to make sure they are receiving high quality testing,” says Dr. Mark Baganz, Founder and Medical Director at Chesapeake Medical Imaging. “Here at CMI, our uncompromising commitment to quality and service affords our patients the most accurate screening and analysis available anywhere.”
CMI… changing the medical imaging experience, one patient at a time. With us, it’s personal.
Annapolis’ Top Radiologist, Dr. Mark Baganz, has been nominated for Ernst & Young’s prestigious Entrepreneur of the Year award for the 2nd consecutive year. Under his leadership, CMI has grown into an innovative healthcare model, providing expert, compassionate care to patients at 14 locations across Baltimore, Annapolis and the Eastern Shore.
Congratulations, Doc, on this well-deserved recognition!
Advances in research and technology are changing medical diagnosis and treatment options across the globe at a dizzying pace. And in Maryland, Chesapeake Medical Imaging is keeping pace -– participating in cutting-edge research, adopting new technologies, and expanding access, without sacrificing the professional expertise and personal service that inspired one of Maryland’s Top Docs to establish the group in 2001.
“When people are sick or injured, they need compassion and kindness, says CMI Founder and Medical Director Dr. Mark Baganz. “Our team is committed to providing the best care and service available anywhere, patients whose very lives may depend on accurate, timely diagnostics.”
Expansion | Expertise
With the addition of three new offices in 2017, CMI now serves patients at 14 locations across Baltimore, Annapolis and the Eastern Shore, allowing for same-day appointments in most cases, and reducing travel time – critical for patients suffering with pain, illness or injury.
Over the past year, CMI welcomed several new physicians to its team, including experts specializing in Musculoskeletal Radiology and MRI.
Among the first to bring 3-D mammography to the area, CMI now employs this new technology exclusively at all its breast imaging locations. “This digital technology lets us locate smaller tumors within individual layers of tissue, allowing for earlier and more accurate diagnosis that can result in extraordinary cure rates,” says Dr. Eva Duckett, renowned breast imaging expert and director of the program at CMI.
As part of a continuing expansion of diagnostic imaging options, CMI now offers Nuclear Medicine (SPECT) at a new state-of-the-art facility in Glen Burnie.
CMI is also among the top 5 Maryland facilities offering DaTscan for Visualization of Dopamine Transporters in Patients with Suspected Parkinsonian Syndromes — a unique study to confirm diagnoses for patients challenged with movement disorders.
To reduce its carbon footprint as well as utility costs, CMI is harnessing the power of the sun to generate electricity at its Annapolis flagship facility. Completed in 2016, the major solar installation includes 176 south-facing panels that generate more than 59,000 kW hours annually — equivalent to the energy it takes to run four average American homes.
In 2017, CMI participated in Imaging Dementia—Evidence for Amyloid Scanning (IDEAS), a $100 million study of nearly 19,000 patients, to determine the clinical usefulness of scanning brain amyloid deposits to help evaluate patients with memory loss.
“With no single test currently available, this imaging represents a potential major advance in assessing people with cognitive impairment, which will provide critical information regarding diagnoses and treatment of those suffering memory loss,” says CMI’s Dr. Kevin Berger, a respected imaging expert in Alzheimer’s disease, who has developed quantitative analysis tools for scan interpretation.
As an independently owned and operated organization, CMI team members make engaging in community charitable and educational efforts a priority. The team annually supports Bras for a Cause, a Breast Cancer Awareness fundraiser held each October in Anne Arundel County, as well as numerous educational events at local schools.
In 2017, other highlights included: Sponsorship of the University of Maryland Baltimore/Washington Medical Center Mission Impossible event, supporting private patient rooms, new operating rooms, and community health care needs; sponsorship of Carver’s Crew, a foundation that supports mid-shore families in the wake of tragedy; a partnership with Johns Hopkins Priority Partners to facilitate mammograms for women in Easton; and sponsorship of Hidden Beauty: Exploring the Aesthetics of Medical Science, a unique exhibit at The Mitchell Gallery, St. John’s College, Annapolis.
Having earned an extraordinary measure of respect among peers, patients and employees, CMI is often formally recognized for providing the highest quality medical imaging services available anywhere, with uncompromising, unparalleled service to patients, their families, referring medical professionals, and the community.
Founder and Medical Director Mark Baganz, M.D. has been ranked a Top Radiologist by What’s Up Magazine since 2005, and was recently nominated for Ernst & Young’s prestigious Entrepreneur of the Year Honor for the second consecutive year.
CMI is also a proud recipient of Top Workplace honors from The Baltimore Sun Media Group for three consecutive years, a recognition of organizational health and workplace culture as experienced by its employees.
Info@cmimail.net | 410.571.0350
Chesapeake Medical Imaging Participates in Major Study
to Improve Alzheimer’s, Dementia Diagnoses
As a registered amyloid PET imaging site, Chesapeake Medical Imaging recently worked with area specialists to participate in Imaging Dementia—Evidence for Amyloid Scanning (IDEAS), a $100 million study to determine the clinical usefulness of scanning brain amyloid deposits to help evaluate patients with memory loss. In all, CMI completed Medicare-covered amyloid PET (positron emission tomography) scans for 136 patients over the past several months.
“We are thrilled to contribute to this important research, which will provide critical information regarding diagnoses, and treatment of those suffering memory loss,” says Dr. Kevin Berger, a respected imaging expert in Alzheimer’s disease, who has developed quantitative analysis tools for scan interpretation.
With no single test currently available, diagnosing Alzheimer’s is based on patient history, physical examination and cognitive testing. Amyloid PET imaging represents a potential major advance in the assessment of people with cognitive impairment, by visualizing plaques in the brain –prime suspects in damaging and killing nerve cells. Previously, these plaques could only be detected by examining the brain at autopsy.
Nearly 19,000 patients are part of the IDEAS study, which is sponsored by the American College of Radiology (ACR) and American College of Radiology Imaging Network, with funding and direction provided by the Alzheimer’s Association, the ACR and the manufacturers of the FDA-approved radiopharmaceuticals for amyloid imaging.
The CMI team looks forward to monitoring the results of the study as they become available, and participating in future trials to support this effort.
Chesapeake Medical Imaging is Maryland’s premier provider of radiology services, with 14 locations across Anne Arundel County, the Baltimore area, and the Eastern Shore.
CMI awarded 2017
Top Workplaces honor
by The Baltimore Sun Media Group
The prestigious selection — based solely on the results of employee feedback — measures numerous aspects of workplace culture.
“Our research has proven that what’s most important to employees is a strong belief in where the organization is headed, how it’s going to get there, and the feeling that everyone is in it together,” says Doug Claffey, CEO of Energage LLC, the leading research firm that conducted the survey. “Without this sense of connection, an organization doesn’t have a shot at being named a Top Workplace.”
The Mitchell Gallery
October 26 – December 10, 2017
CMI is pleased to sponsor this collaborative project by a scientist and an artist from the Johns Hopkins University School of Medicine, which asks the viewer to consider the aesthetics of human disease, a dynamically powerful force of nature that acts without regard to race, religion, or culture.
More than sixty medical science professionals present photographs of visually stunning patterns of different diseases affecting various areas of the human anatomy in this exhibition. Captured with a variety of imaging technology that range from spectral karyotyping to scanning electron microscopy, we see beauty in the delicate lacework of fungal hyphae invading a blood vessel, the structure of the normal cerebellum, and the desperate drive of metastasizing cancer cells. Ultimately, this series of images will leave the viewer with an understanding and appreciation of visual beauty inherent within the field of modern medical science.
This exhibition is a collaborative exhibition and book by Norman Barker & Christine Iacobuzio-Donahue.
Sponsored by: Chesapeake Medical Imaging
In addition to providing an unparalleled level of service to our patients, their families and referring physicians, and the highest quality medical imaging available anywhere in the world, we are committed to providing the best work environment possible for our employees and the continued growth of our organization.
Learn more about current career opportunities in White Marsh, Bowie and Glen Burnie
Chesapeake Medical Imaging is the region’s premier medical imaging facility. Our medical, technical and clerical staff are among the most experienced in the industry and our medical imaging equipment is the finest in the world. Unlike other medical imaging facilities that are owned and operated by large healthcare organizations or by non-medical personnel, we are owned and operated by dedicated medical and technical professionals so you can be assured that your visit will be personal, confidential and professional.
Dr. Mark Baganz Named Top Radiologist for 2017-2018
Chesapeake Medical Imaging Annapolis & Easton Best in Radiology
Congratulations to Dr. Mark Baganz, who has again been named a What’s Up Magazine Top Doctor, and kudos to the Chesapeake Medical Imaging (CMI) team on first-time honors as Best of Annapolis and Best of Eastern Shore in Radiology.
“Excellence in service and care is what we are all about, and we appreciate the What’s Up Magazine folks for their great work in polling and informing people about area providers,” says Dr. Baganz. “Of course, the votes of our patients and their doctors are what make this recognition meaningful; and we are honored to be partners in their diagnostic and preventative health care.”
Dr. Baganz founded CMI in 2001 to provide the highest quality radiology services available anywhere. Under his leadership, CMI has achieved remarkable success, growing from its initial Annapolis facility to 14 locations across the region.
The 2017-2018 What’s Up magazine recognition marks a dozen years for Dr. Baganz as a Top Doc, who’s first recognition was in 2005. In June, Dr. Baganz was named a Maryland finalist in the Ernst and Young Entrepreneur of the Year Program.
CMI received 2016 Top Workplace recognition in the Baltimore Sun annual survey of area employees, for the third consecutive year.
Consistently adopting new technologies, CMI now offers patients’ state-of-the-art 3-D mammography screening in Annapolis and Easton, and nuclear medicine testing in Glen Burnie.
Reducing their carbon footprint, CMI has installed a 50-kW solar system at its Annapolis facility. The rooftop panels generate more than 59,000 kW hours annually (equivalent to the energy it takes to run 4 average American homes) and is expected to save as much as $30,000.